Skip to main content
. 2021 Aug 10;13(16):4033. doi: 10.3390/cancers13164033
CD Cluster of Differentiation
CR Complete Response
ctDNA circulating tumor DNA
CTLA-4 Cytotoxic T-Lymphocyte-Associated protein 4
DFS Disease-Free Survival
EFS Event-Free Survival
ERAS Enhanced Recovery After Surgery
ICI Immune Checkpoint Inhibitor
LAG-3 Lymphocyte-Activation Gene 3
MPR Major Pathological Response
NSCLC Non-Small Cell Lung Cancer
ORR Objective Response Rate
OS Overall Survival
pCR Pathological Complete Response
PD Progressive Disease
PD-1 Programmed cell Death protein 1
PD-L1 Programmed Death Ligand 1
PFS Progression-Free Survival
PR Partial Response
RATS Robotic-Assisted Thoracic Surgery
SCLC Small Cell Lung Cancer
SD Stable Disease
TILs Tumor Infiltrating Lymphocytes
TMB Tumor Mutational Burden
VATS Video-Assisted Thoracic Surgery